Opening book details…
About this Medicine article
A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma by Monika Jermann; Rolf A Stahel; Marc Salzberg; Thomas Cerny; Markus Joerger; Silke Gillessen; Rudolf Morant; Fritz Egli; Kaspar Rhyner; Jean A Bauer; Miklos Pless is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Monika Jermann; Rolf A Stahel; Marc Salzberg; Thomas Cerny; Markus Joerger; Silke Gillessen; Rudolf Morant; Fritz Egli; Kaspar Rhyner; Jean A Bauer; Miklos Pless
- Publisher
- Springer; Springer-Verlag; Springer Verlag; Springer Science and Business Media LLC (ISSN 0344-5704)
- Published
- 2005
- Field
- Medicine (Health Sciences)